p97 dysfunction underlies a loss of quality control of damaged membrane proteins and promotes oxidative stress and sickling in sickle cell disease.

Autor: Song A; Department of Biochemistry and Molecular Biology, the University of Texas McGovern Medical School, Houston, Texas, USA., Wen AQ; Department of Biochemistry and Molecular Biology, the University of Texas McGovern Medical School, Houston, Texas, USA.; University of California at San Diego, La Jolla, California, USA., Wen YE; Department of Biochemistry and Molecular Biology, the University of Texas McGovern Medical School, Houston, Texas, USA.; University of Texas Southwestern Medical School, Dallas, Texas, USA., Dzieciatkowska M; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA., Kellems RE; Department of Biochemistry and Molecular Biology, the University of Texas McGovern Medical School, Houston, Texas, USA.; Graduate Program in Biochemistry and Cell Biology, University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., Juneja HS; Department of Internal Medicine, Divison of Hematology, the University of Texas McGovern Medical School, Houston, Texas, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA., Xia Y; Department of Biochemistry and Molecular Biology, the University of Texas McGovern Medical School, Houston, Texas, USA.; Graduate Program in Biochemistry and Cell Biology, University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2022 May; Vol. 36 (5), pp. e22246.

Mass-forming neoplastic extramedullary hematopoiesis mimics myeloid sarcoma in a patient with chronic phase chronic myeloid leukemia.

Autor: Hu Z; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Singhi EK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Apostolidou E; Hematology Division, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Mai B; Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Juneja HS; Hematology Division, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2021 Jun; Vol. 43 (3), pp. e135-e137. Date of Electronic Publication: 2020 Dec 13.

Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.

Autor: Vahidy FS; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Haque ME; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Rahbar MH; Biostatistics/Epidemiology/Research Design (BERD) Core, Center for Clinical and Translational Sciences (CCTS), UTHealth, Houston, Texas, USA., Zhu H; Department of Biostatistics and Data Science, School of Public Health, UTHealth, Houston, Texas, USA., Rowan P; Department of Health Policy and Management, School of Public Health, UTHealth, Houston, Texas, USA., Aisiku IP; Division of Emergency Critical Care, Department of Emergency Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee DA; Division of Pediatrics, Cell Therapy Section, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Juneja HS; Hematology Division, Department of Medicine, UTHealth, Houston, Texas, USA., Alderman S; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Barreto AD; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Suarez JI; Division of Neurosciences Critical Care, Department of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bambhroliya A; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Hasan KM; Department of Diagnostic and Interventional Imaging, McGovern Medical School at UTHealth, Houston, Texas, USA., Kassam MR; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Aronowski J; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA., Gee A; Department of Medicine and Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA., Cox CS Jr; Department of Pediatric Surgery, McGovern Medical School at UTHealth, Houston, Texas, USA., Grotta JC; Memorial Hermann Health System, Houston, Texas, USA., Savitz SI; Institute for Stroke and Cerebrovascular Disease and Department of Neurology, McGovern Medical School at UTHealth, Houston, Texas, USA.

Publikováno v: Stem cells (Dayton, Ohio) [Stem Cells] 2019 Nov; Vol. 37 (11), pp. 1481-1491. Date of Electronic Publication: 2019 Sep 17.

Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.

Autor: Sun K; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Graduate School of Biomedical Science, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA., Ahmed MH; Department of Medicinal Chemistry, and The Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA., Zhang Y; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Song A; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Ko TP; Department of Medicinal Chemistry, and The Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA., Nemkov T; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA., Reisz JA; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA., Wu H; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Adebiyi M; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Graduate School of Biomedical Science, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Peng Z; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Gong J; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Liu H; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Graduate School of Biomedical Science, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Huang A; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Wen YE; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Wen AQ; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Berka V; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA., Bogdanov MV; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Abdulmalik O; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA., Han L; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Tsai AL; Department of Internal Medicine-Hematology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Idowu M; Department of Internal Medicine-Hematology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Juneja HS; Department of Internal Medicine-Hematology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Kellems RE; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.; Graduate School of Biomedical Science, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Dowhan W; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Hansen KC; Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 80045, USA., Safo MK; Department of Medicinal Chemistry, and The Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA., Xia Y; Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. yang.xia@uth.tmc.edu.; Graduate School of Biomedical Science, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. yang.xia@uth.tmc.edu.; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. yang.xia@uth.tmc.edu.

Publikováno v: Scientific reports [Sci Rep] 2017 Nov 10; Vol. 7 (1), pp. 15281. Date of Electronic Publication: 2017 Nov 10.

Bioinformatic network analysis on the molecular interactions between Parkinson's disease, alpha-synuclein, and infertility condition.

Autor: Krishnan, Velu, Patel, Shivani S., Shenoy, Priyanka, Cottrell, Jessica jessica.cottrell@shu.edu

Publikováno v: Middle East Fertility Society Journal. Dec2023, Vol. 28 Issue 1, p1-16. 16p.